{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:04:40Z","timestamp":1785423880827,"version":"3.56.0"},"reference-count":219,"publisher":"Journal of Biomedical Research","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.40.20260243","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:26:23Z","timestamp":1782541583000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["The immunological landscape of viral infections in asthma: mechanistic insights and therapeutic paradigm shifts"],"prefix":"10.7555","volume":"40","author":[{"given":"Juntong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.1","doi-asserted-by":"crossref","unstructured":"Lemanske RF Jr, Busse WW. Asthma[J]. <i>JAMA<\/i>, 1997, 278(22): 1855\u20131873.","DOI":"10.1001\/jama.1997.03550220061010"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children[J]. <i>BMJ<\/i>, 1995, 310(6989): 1225\u20131229.","DOI":"10.1136\/bmj.310.6989.1225"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults[J]. <i>BMJ<\/i>, 1993, 307(6910): 982\u2013986.","DOI":"10.1136\/bmj.307.6910.982"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Rosas-Salazar C, Chirkova T, Gebretsadik T, et al. Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): A population-based, prospective birth cohort study[J]. <i>Lancet<\/i>, 2023, 401(10389): 1669\u20131680.","DOI":"10.1016\/S0140-6736(23)00811-5"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Gerke AK, Yang M, Tang F, et al. Association of hospitalizations for asthma with seasonal and pandemic influenza[J]. <i>Respirology<\/i>, 2014, 19(1): 116\u2013121.","DOI":"10.1111\/resp.12165"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing[J]. <i>J Allergy Clin Immunol<\/i>, 2004, 114(2): 239\u2013247.","DOI":"10.1016\/j.jaci.2004.04.006"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Jartti T, B\u00f8nnelykke K, Elenius V, et al. Role of viruses in asthma[J]. <i>Semin Immunopathol<\/i>, 2020, 42(1): 61\u201374.","DOI":"10.1007\/s00281-020-00781-5"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Marcellini A, Swieboda D, Gued\u00e1n A, et al. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication[J]. <i>Eur J Pharmacol<\/i>, 2021, 893: 173839.","DOI":"10.1016\/j.ejphar.2020.173839"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma[J]. <i>J Allergy Clin Immunol<\/i>, 2007, 119(2): 314\u2013321.","DOI":"10.1016\/j.jaci.2006.08.041"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Giardina FAM, Piralla A, Ferrari G, et al. Molecular epidemiology of rhinovirus\/enterovirus and their role on cause severe and prolonged infection in hospitalized patients[J]. <i>Microorganisms<\/i>, 2022, 10(4): 755.","DOI":"10.3390\/microorganisms10040755"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence[J]. <i>J Allergy Clin Immunol<\/i>, 2017, 139(2): 501\u2013507.","DOI":"10.1016\/j.jaci.2016.03.049"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze[J]. <i>Lancet<\/i>, 2014, 383(9928): 1593\u20131604.","DOI":"10.1016\/S0140-6736(14)60615-2"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.13","doi-asserted-by":"crossref","unstructured":"Mehta AK, Duan W, Doerner AM, et al. Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33[J]. <i>J Allergy Clin Immunol<\/i>, 2016, 137(1): 278\u2013288. e6.","DOI":"10.1016\/j.jaci.2015.05.007"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Jackson DJ, Makrinioti H, Rana BMJ, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations <i>in vivo<\/i>[J]. <i>Am J Respir Crit Care Med<\/i>, 2014, 190(12): 1373\u20131382.","DOI":"10.1164\/rccm.201406-1039OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life[J]. <i>Am J Respir Crit Care Med<\/i>, 2012, 185(3): 281\u2013285.","DOI":"10.1164\/rccm.201104-0660OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Van Benten I, Koopman L, Niesters B, et al. Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants[J]. <i>Pediatr Allergy Immunol<\/i>, 2003, 14(5): 363\u2013370.","DOI":"10.1034\/j.1399-3038.2003.00064.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Wood LG, Powell H, Grissell TV, et al. Persistence of rhinovirus RNA and IP-10 gene expression after acute asthma[J]. <i>Respirology<\/i>, 2011, 16(2): 291\u2013299.","DOI":"10.1111\/j.1440-1843.2010.01897.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Wo\u015b M, Sanak M, Soja J, et al. The presence of rhinovirus in lower airways of patients with bronchial asthma[J]. <i>Am J Respir Crit Care Med<\/i>, 2008, 177(10): 1082\u20131089.","DOI":"10.1164\/rccm.200607-973OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Bizzintino J, Lee WM, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children[J]. <i>Eur Respir J<\/i>, 2011, 37(5): 1037\u20131042.","DOI":"10.1183\/09031936.00092410"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Sayama A, Okamoto M, Tamaki R, et al. Comparison of rhinovirus A-, B-, and C-associated respiratory tract illness severity based on the 5'-untranslated region among children younger than 5 years[J]. <i>Open Forum Infect Dis<\/i>, 2022, 9(10): ofac387.","DOI":"10.1093\/ofid\/ofac387"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Stenberg Hammar K, Niespodziana K, van Hage M, et al. Reduced <i>CDHR3<\/i> expression in children wheezing with rhinovirus[J]. <i>Pediatr Allergy Immunol<\/i>, 2018, 29(2): 200\u2013206.","DOI":"10.1111\/pai.12858"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7[J]. <i>Am J Respir Crit Care Med<\/i>, 2000, 161(5): 1501\u20131507.","DOI":"10.1164\/ajrccm.161.5.9906076"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13[J]. <i>Am J Respir Crit Care Med<\/i>, 2005, 171(2): 137\u2013141.","DOI":"10.1164\/rccm.200406-730oc"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Scheltema NM, Nibbelke EE, Pouw J, et al. Respiratory syncytial virus prevention and asthma in healthy preterm infants: A randomised controlled trial[J]. <i>Lancet Respir Med<\/i>, 2018, 6(4): 257\u2013264.","DOI":"10.1016\/S2213-2600(18)30055-9"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Yoshihara S, Kusuda S, Mochizuki H, et al. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants[J]. <i>Pediatrics<\/i>, 2013, 132(5): 811\u2013818.","DOI":"10.1542\/peds.2013-0982"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Kato M, Mochizuki H, Kama Y, et al. Palivizumab prophylaxis in preterm infants and subsequent wheezing\/asthma: 10-year follow-up study[J]. <i>Pediatr Pulmonol<\/i>, 2024, 59(3): 743\u2013749.","DOI":"10.1002\/ppul.26824"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Puthothu B, Krueger M, Forster J, et al. Association between severe respiratory syncytial virus infection and <i>IL13\/IL4<\/i> haplotypes[J]. <i>J Infect Dis<\/i>, 2006, 193(3): 438\u2013441.","DOI":"10.1086\/499316"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Caballero MT, Serra ME, Acosta PL, et al. <i>TLR4<\/i> genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization[J]. <i>J Clin Invest<\/i>, 2015, 125(2): 571\u2013582.","DOI":"10.1172\/JCI75183"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"Kuehni CE, Spycher BD, Silverman M. A role for genes and environment in the causal relationship between infant RSV infection and childhood asthma[J]. <i>Am J Respir Crit Care Med<\/i>, 2010, 181(2): 195.","DOI":"10.1164\/ajrccm.181.2.195"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Mullins JA, Erdman DD, Weinberg GA, et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness[J]. <i>Emerg Infect Dis<\/i>, 2004, 10(4): 700\u2013705.","DOI":"10.3201\/eid1004.030555"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children[J]. <i>N Engl J Med<\/i>, 2004, 350(5): 443\u2013450.","DOI":"10.1056\/NEJMoa025472"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Kan-O K, Washio Y, Fujimoto T, et al. Differences in the spectrum of respiratory viruses and detection of human rhinovirus C in exacerbations of adult asthma and chronic obstructive pulmonary disease[J]. <i>Respir Investig<\/i>, 2022, 60(1): 129\u2013136.","DOI":"10.1016\/j.resinv.2021.08.009"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Liu J, Wang Y, Zou L, et al. Salt-inducible kinase 1 is a key gene in suppressing EVD68-induced asthma by modulating antiviral immunity[J]. <i>Genes Dis<\/i>, 2026, 13(3): 101845.","DOI":"10.1016\/j.gendis.2025.101845"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Chen T, Wang X, Zhang G, et al. Curcuminoids amplify host innate antiviral immunity via the CRYAB-RBM26 axis in viral infection[J]. <i>iMeta<\/i>, 2026, 5(1): e70111.","DOI":"10.1002\/imt2.70111"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.35","doi-asserted-by":"publisher","unstructured":"Wang YC, Tsai CS, Yang YH, et al. Association between enterovirus infection and asthma in children: A 16-year nationwide population-based cohort study[J]. <i>Pediatr Infect Dis J<\/i>, 2018, 37(9): 844\u2013849.","DOI":"10.1097\/INF.0000000000001918"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.36","doi-asserted-by":"publisher","unstructured":"Chen P, Shao Y, Hsieh MH, et al. Early-life EV-A71 infection augments allergen-induced airway inflammation in asthma through trained macrophage immunity[J]. <i>Cell Mol Immunol<\/i>, 2021, 18(2): 472\u2013483.","DOI":"10.1038\/s41423-020-00621-4"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.37","doi-asserted-by":"crossref","unstructured":"Moss RB. Enterovirus 68 infection-association with asthma[J]. <i>J Allergy Clin Immunol Pract<\/i>, 2016, 4(2): 226\u2013228.","DOI":"10.1016\/j.jaip.2015.12.013"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.38","doi-asserted-by":"publisher","unstructured":"Korematsu S, Nagashima K, Sato Y, et al. \"Spike\" in acute asthma exacerbations during enterovirus D68 epidemic in Japan: A nation-wide survey[J]. <i>Allergol Int<\/i>, 2018, 67(1): 55\u201360.","DOI":"10.1016\/j.alit.2017.04.003"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.39","doi-asserted-by":"publisher","unstructured":"Hasegawa S, Hirano R, Okamoto-Nakagawa R, et al. Enterovirus 68 infection in children with asthma attacks: Virus-induced asthma in Japanese children[J]. <i>Allergy<\/i>, 2011, 66(12): 1618\u20131620.","DOI":"10.1111\/j.1398-9995.2011.02725.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.40","doi-asserted-by":"publisher","unstructured":"Switzer C, Verschoor CP, Gavina K, et al. Likelihood of hospitalization for a chronic respiratory condition following pediatric infection with enterovirus and rhinovirus strains[J]. <i>Infect Med (Beijing)<\/i>, 2022, 1(4): 245\u2013252.","DOI":"10.1016\/j.imj.2022.10.002"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.41","doi-asserted-by":"publisher","unstructured":"S\u00f6derlund-Venermo M, Lahtinen A, Jartti T, et al. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland[J]. <i>Emerg Infect Dis<\/i>, 2009, 15(9): 1423\u20131430.","DOI":"10.3201\/eid1509.090204"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.42","doi-asserted-by":"publisher","unstructured":"del Rosal T, Garc\u00eda-Garc\u00eda ML, Calvo C, et al. Recurrent wheezing and asthma after bocavirus bronchiolitis[J]. <i>Allergol Immunopathol (Madr)<\/i>, 2016, 44(5): 410\u2013414.","DOI":"10.1016\/j.aller.2015.07.004"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.43","doi-asserted-by":"publisher","unstructured":"Garcia-Garcia ML, Calvo Rey C, del Rosal Rabes T. Pediatric asthma and viral infection[J]. <i>Arch Bronconeumol (Engl Ed)<\/i>, 2016, 52(5): 269\u2013273.","DOI":"10.1016\/j.arbr.2016.03.010"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.44","doi-asserted-by":"publisher","unstructured":"Coverstone AM, Wang L, Sumino K. Beyond respiratory syncytial virus and rhinovirus in the pathogenesis and exacerbation of asthma: The role of metapneumovirus, bocavirus and influenza virus[J]. <i>Immunol Allergy Clin North Am<\/i>, 2019, 39(3): 391\u2013401.","DOI":"10.1016\/j.iac.2019.03.007"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.45","doi-asserted-by":"crossref","unstructured":"Busse WW, Peters SP, Fenton MJ, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine[J]. <i>J Allergy Clin Immunol<\/i>, 2011, 127(1): 130\u2013137. e3.","DOI":"10.1016\/j.jaci.2010.11.014"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.46","doi-asserted-by":"publisher","unstructured":"Ernst P, Ariel A, Suissa S. Differences between asthmatics and nonasthmatics hospitalised with influenza A infection[J]. <i>Eur Respir J<\/i>, 2013, 41(4): 772\u2013774.","DOI":"10.1183\/09031936.00137812"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.47","doi-asserted-by":"publisher","unstructured":"Jha A, Dunning J, Tunstall T, et al. Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza[J]. <i>Eur Respir J<\/i>, 2019, 54(4): 1900949.","DOI":"10.1183\/13993003.00949-2019"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.48","doi-asserted-by":"publisher","unstructured":"Iikura M, Hojo M, Koketsu R, et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice[J]. <i>PLoS One<\/i>, 2015, 10(4): e0123584.","DOI":"10.1371\/journal.pone.0123584"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.49","doi-asserted-by":"publisher","unstructured":"Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma[J]. <i>Chest<\/i>, 1997, 112(3): 591\u2013596.","DOI":"10.1378\/chest.112.3.591"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.50","doi-asserted-by":"publisher","unstructured":"Tan WC, Xiang X, Qiu D, et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease[J]. <i>Am J Med<\/i>, 2003, 115(4): 272\u2013277.","DOI":"10.1016\/S0002-9343(03)00353-X"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.51","doi-asserted-by":"publisher","unstructured":"Atmar RL, Guy E, Guntupalli KK, et al. Respiratory tract viral infections in inner-city asthmatic adults[J]. <i>Arch Intern Med<\/i>, 1998, 158(22): 2453\u20132459.","DOI":"10.1542\/peds.104.s2.372a"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.52","doi-asserted-by":"publisher","unstructured":"You L, Zhang Z, Li H, et al. Exploring the respiratory viral landscape beyond influenza and SARS-CoV-2: A 2020\u20132023 study in Fujian, China[J]. <i>Front Public Health<\/i>, 2025, 13: 1558716.","DOI":"10.3389\/fpubh.2025.1558716"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.53","doi-asserted-by":"publisher","unstructured":"Izquierdo JL, Almonacid C, Gonz\u00e1lez Y, et al. The impact of COVID-19 on patients with asthma[J]. <i>Eur Respir J<\/i>, 2021, 57(3): 2003142.","DOI":"10.1183\/13993003.03142-2020"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.54","doi-asserted-by":"publisher","unstructured":"Choi YJ, Park JY, Lee HS, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19[J]. <i>Eur Respir J<\/i>, 2021, 57(3): 2002226.","DOI":"10.1183\/13993003.02226-2020"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.55","doi-asserted-by":"crossref","unstructured":"Zhu Z, Hasegawa K, Ma B, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19[J]. <i>J Allergy Clin Immunol<\/i>, 2020, 146(2): 327\u2013329. e4.","DOI":"10.1016\/j.jaci.2020.06.001"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.56","doi-asserted-by":"publisher","unstructured":"Lombardi C, Gani F, Berti A, et al. Asthma and COVID-19: A dangerous liaison?[J]. <i>Asthma Res Pract<\/i>, 2021, 7(1): 9.","DOI":"10.1186\/s40733-021-00075-z"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.57","doi-asserted-by":"publisher","unstructured":"Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study[J]. <i>J Allergy Clin Immunol<\/i>, 2020, 146(4): 790\u2013798.","DOI":"10.1016\/j.jaci.2020.08.008"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.58","doi-asserted-by":"crossref","unstructured":"Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor <i>ACE2<\/i>[J]. <i>J Allergy Clin Immunol<\/i>, 2020, 146(1): 203\u2013206. e3.","DOI":"10.1016\/j.jaci.2020.04.009"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.59","doi-asserted-by":"crossref","unstructured":"Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells[J]. <i>J Allergy Clin Immunol<\/i>, 2020, 146(1): 80\u201388. e8.","DOI":"10.1016\/j.jaci.2020.05.004"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.60","doi-asserted-by":"publisher","unstructured":"Matsumoto K, Saito H. Does asthma affect morbidity or severity of COVID-19?[J]. <i>J Allergy Clin Immunol<\/i>, 2020, 146(1): 55\u201357.","DOI":"10.1016\/j.jaci.2020.05.017"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.61","doi-asserted-by":"publisher","unstructured":"Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1\u201330, 2020[J]. <i>MMWR Morb Mortal Wkly Rep<\/i>, 2020, 69(15): 458\u2013464.","DOI":"10.15585\/mmwr.mm6915e3"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.62","doi-asserted-by":"publisher","unstructured":"Beurnier A, Jutant EM, Jevnikar M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation[J]. <i>Eur Respir J<\/i>, 2020, 56(5): 2001875.","DOI":"10.1183\/13993003.01875-2020"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.63","doi-asserted-by":"publisher","unstructured":"Grandbastien M, Piotin A, Godet J, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation[J]. <i>J Allergy Clin Immunol Pract<\/i>, 2020, 8(8): 2600\u20132607.","DOI":"10.1016\/j.jaip.2020.06.032"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.64","doi-asserted-by":"publisher","unstructured":"Michi AN, Yipp BG, Dufour A, et al. PGC-1\u03b1 mediates a metabolic host defense response in human airway epithelium during rhinovirus infections[J]. <i>Nat Commun<\/i>, 2021, 12(1): 3669.","DOI":"10.1038\/s41467-021-23925-z"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.65","doi-asserted-by":"publisher","unstructured":"Guo-Parke H, Canning P, Douglas I, et al. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium[J]. <i>Am J Respir Crit Care Med<\/i>, 2013, 188(7): 842\u2013851.","DOI":"10.1164\/rccm.201304-0750OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.66","doi-asserted-by":"publisher","unstructured":"Tristram DA, Hicks W Jr, Hard R. Respiratory syncytial virus and human bronchial epithelium[J]. <i>Arch Otolaryngol Head Neck Surg<\/i>, 1998, 124(7): 777\u2013783.","DOI":"10.1001\/archotol.124.7.777"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.67","doi-asserted-by":"publisher","unstructured":"Jacoby DB, Tamaoki J, Borson DB, et al. Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase[J]. <i>J Appl Physiol (1985)<\/i>, 1988, 64(6): 2653\u20132658.","DOI":"10.1152\/jappl.1988.64.6.2653"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.68","doi-asserted-by":"publisher","unstructured":"Bucchieri F, Puddicombe SM, Lordan JL, et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis[J]. <i>Am J Respir Cell Mol Biol<\/i>, 2002, 27(2): 179\u2013185.","DOI":"10.1165\/ajrcmb.27.2.4699"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.69","doi-asserted-by":"publisher","unstructured":"Hackett TL, Warner SM, Stefanowicz D, et al. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-\u03b21[J]. <i>Am J Respir Crit Care Med<\/i>, 2009, 180(2): 122\u2013133.","DOI":"10.1164\/rccm.200811-1730OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.70","doi-asserted-by":"publisher","unstructured":"Raby KL, Michaeloudes C, Tonkin J, et al. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD[J]. <i>Front Immunol<\/i>, 2023, 14: 1201658.","DOI":"10.3389\/fimmu.2023.1201658"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.71","doi-asserted-by":"publisher","unstructured":"Shi N, Zhang J, Chen S. DOCK2 promotes asthma development by eliciting airway epithelial-mesenchymal transition[J]. <i>Am J Respir Cell Mol Biol<\/i>, 2023, 69(3): 310\u2013320.","DOI":"10.1165\/rcmb.2022-0273OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.72","doi-asserted-by":"publisher","unstructured":"Liu Y, Tan X, Yang H, et al. Wnt5a-mediated autophagy contributes to the epithelial-mesenchymal transition of human bronchial epithelial cells during asthma[J]. <i>Mol Med<\/i>, 2024, 30(1): 93.","DOI":"10.1186\/s10020-024-00862-3"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.73","unstructured":"Yamaguchi M, Niimi A, Matsumoto H, et al. Sputum levels of transforming growth factor-beta1 in asthma: Relation to clinical and computed tomography findings[J]. <i>J Investig Allergol Clin Immunol<\/i>, 2008, 18(3): 202\u2013206."},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.74","doi-asserted-by":"publisher","unstructured":"Yang W, Bai X, Li H, et al. Influenza A and B virus-triggered epithelial-mesenchymal transition is relevant to the binding ability of NA to latent TGF-\u03b2[J]. <i>Front Microbiol<\/i>, 2022, 13: 841462.","DOI":"10.3389\/fmicb.2022.841462"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.75","doi-asserted-by":"publisher","unstructured":"Hewitt RJ, Lloyd CM. Regulation of immune responses by the airway epithelial cell landscape[J]. <i>Nat Rev Immunol<\/i>, 2021, 21(6): 347\u2013362.","DOI":"10.1038\/s41577-020-00477-9"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.76","doi-asserted-by":"publisher","unstructured":"Ye L, Schnepf D, Staeheli P. Interferon-\u03bb orchestrates innate and adaptive mucosal immune responses[J]. <i>Nat Rev Immunol<\/i>, 2019, 19(10): 614\u2013625.","DOI":"10.1038\/s41577-019-0182-z"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.77","doi-asserted-by":"publisher","unstructured":"Gaberino CL, Altman MC, Gill MA, et al. Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban children[J]. <i>J Allergy Clin Immunol<\/i>, 2025, 155(5): 1499\u20131509.","DOI":"10.1016\/j.jaci.2024.12.1090"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.78","doi-asserted-by":"publisher","unstructured":"Wark PAB, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus[J]. <i>J Exp Med<\/i>, 2005, 201(6): 937\u2013947.","DOI":"10.1084\/jem.20041901"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.79","doi-asserted-by":"publisher","unstructured":"Dill-McFarland KA, Schwartz JT, Zhao H, et al. Eosinophil-mediated suppression and anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma[J]. <i>J Allergy Clin Immunol<\/i>, 2022, 150(3): 666\u2013675.","DOI":"10.1016\/j.jaci.2022.03.025"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.80","doi-asserted-by":"publisher","unstructured":"Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-\u03bb production in asthma exacerbations[J]. <i>Nat Med<\/i>, 2006, 12(9): 1023\u20131026.","DOI":"10.1038\/nm1462"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.81","doi-asserted-by":"publisher","unstructured":"Bochkov YA, Hanson KM, Keles S, et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma[J]. <i>Mucosal Immunol<\/i>, 2010, 3(1): 69\u201380.","DOI":"10.1038\/mi.2009.109"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.82","doi-asserted-by":"crossref","unstructured":"Lopez-Souza N, Favoreto S, Wong H, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects[J]. <i>J Allergy Clin Immunol<\/i>, 2009, 123(6): 1384\u20131390. e2.","DOI":"10.1016\/j.jaci.2009.03.010"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.83","doi-asserted-by":"publisher","unstructured":"Pritchard AL, White OJ, Burel JG, et al. Asthma is associated with multiple alterations in anti-viral innate signalling pathways[J]. <i>PLoS One<\/i>, 2014, 9(9): e106501.","DOI":"10.1371\/journal.pone.0106501"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.84","doi-asserted-by":"publisher","unstructured":"Saikh KU, Ranji CM. Cells stimulated with more than one toll-like receptor-ligand in the presence of a MyD88 inhibitor augmented interferon-<i>\u03b2<\/i> via MyD88-independent signaling pathway[J]. <i>Viral Immunol<\/i>, 2021, 34(9): 646\u2013652.","DOI":"10.1089\/vim.2021.0020"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.85","doi-asserted-by":"crossref","unstructured":"Zhu J, Message SD, Mallia P, et al. Bronchial mucosal IFN-\u03b1\/\u03b2 and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations[J]. <i>J Allergy Clin Immunol<\/i>, 2019, 143(1): 114\u2013125. e4.","DOI":"10.1016\/j.jaci.2018.04.003"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.86","doi-asserted-by":"publisher","unstructured":"Esquivel A, Busse WW, Calatroni A, et al. Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma[J]. <i>Am J Respir Crit Care Med<\/i>, 2017, 196(8): 985\u2013992.","DOI":"10.1164\/rccm.201701-0120OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.87","doi-asserted-by":"publisher","unstructured":"Zhang H, Xue K, Li W, et al. Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity[J]. <i>Nat Commun<\/i>, 2024, 15(1): 252.","DOI":"10.1038\/s41467-023-44168-0"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.88","doi-asserted-by":"publisher","unstructured":"Rebuffet L, Melsen JE, Escali\u00e8re B, et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity[J]. <i>Nat Immunol<\/i>, 2024, 25(8): 1474\u20131488.","DOI":"10.1038\/s41590-024-01883-0"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.89","doi-asserted-by":"publisher","unstructured":"Chen S, Zhu H, Jounaidi Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization[J]. <i>Signal Transduct Target Ther<\/i>, 2024, 9(1): 302.","DOI":"10.1038\/s41392-024-02005-w"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.90","doi-asserted-by":"publisher","unstructured":"Duvall MG, Barnig C, Cernadas M, et al. Natural killer cell-mediated inflammation resolution is disabled in severe asthma[J]. <i>Sci Immunol<\/i>, 2017, 2(9): eaam5446.","DOI":"10.1126\/sciimmunol.aam5446"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.91","doi-asserted-by":"publisher","unstructured":"Devulder J, Chenivesse C, Ledroit V, et al. Aberrant anti-viral response of natural killer cells in severe asthma[J]. <i>Eur Respir J<\/i>, 2020, 55(5): 1802422.","DOI":"10.1183\/13993003.02422-2018"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.92","doi-asserted-by":"publisher","unstructured":"Wei H, Zhang J, Xiao W, et al. Involvement of human natural killer cells in asthma pathogenesis: Natural killer 2 cells in type 2 cytokine predominance[J]. <i>J Allergy Clin Immunol<\/i>, 2005, 115(4): 841\u2013847.","DOI":"10.1016\/j.jaci.2004.11.026"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.93","doi-asserted-by":"publisher","unstructured":"Lepretre F, Gras D, Chanez P, et al. Natural killer cells in the lung: Potential role in asthma and virus-induced exacerbation?[J]. <i>Eur Respir Rev<\/i>, 2023, 32(169): 230036.","DOI":"10.1183\/16000617.0036-2023"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.94","doi-asserted-by":"publisher","unstructured":"Xu J, Cao S, Xu Y, et al. The role of DC subgroups in the pathogenesis of asthma[J]. <i>Front Immunol<\/i>, 2024, 15: 1481989.","DOI":"10.3389\/fimmu.2024.1481989"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.95","doi-asserted-by":"publisher","unstructured":"Thio CLP, Shao JS, Luo CH, et al. Decoding innate lymphoid cells and innate-like lymphocytes in asthma: Pathways to mechanisms and therapies[J]. <i>J Biomed Sci<\/i>, 2025, 32(1): 48.","DOI":"10.1186\/s12929-025-01142-w"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.96","doi-asserted-by":"publisher","unstructured":"Lambrecht BN, Hammad H. The other cells in asthma: Dendritic cell and epithelial cell crosstalk[J]. <i>Curr Opin Pulm Med<\/i>, 2003, 9(1): 34\u201341.","DOI":"10.1097\/00063198-200301000-00006"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.97","doi-asserted-by":"crossref","unstructured":"Hoogsteden HC, Verhoeven GT, Lambrecht BN, et al. Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigen-presenting dendritic cell: Influence of treatment with fluticasone propionate[J]. <i>Clin Exp Allergy<\/i>, 1999, 29 Suppl 2: 116\u2013124.","DOI":"10.1046\/j.1365-2222.1999.00020.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.98","doi-asserted-by":"publisher","unstructured":"Huang HJ, Lin YL, Liu CF, et al. Mite allergen decreases DC-SIGN expression and modulates human dendritic cell differentiation and function in allergic asthma[J]. <i>Mucosal Immunol<\/i>, 2011, 4(5): 519\u2013527.","DOI":"10.1038\/mi.2011.17"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.99","doi-asserted-by":"publisher","unstructured":"Horlock C, Shakib F, Jones NS, et al. Differential protein expression by dendritic cells from atopic and non-atopic individuals after stimulation by the major house dust mite allergen Der p 1[J]. <i>Int Arch Allergy Immunol<\/i>, 2009, 150(3): 237\u2013251.","DOI":"10.1159\/000222676"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.100","doi-asserted-by":"publisher","unstructured":"Pilette C, Jacobson MR, Ratajczak C, et al. Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis[J]. <i>Allergy<\/i>, 2013, 68(3): 312\u2013321.","DOI":"10.1111\/all.12090"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.101","doi-asserted-by":"crossref","unstructured":"Lambrecht BN, Hammad H. Dendritic cell and epithelial cell interactions at the origin of murine asthma[J]. <i>Ann Am Thorac Soc<\/i>, 2014, 11 Suppl 5: S236\u2013S243.","DOI":"10.1513\/AnnalsATS.201405-218AW"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.102","doi-asserted-by":"crossref","unstructured":"Bonser LR, Erle DJ. The airway epithelium in asthma[J]. <i>Adv Immunol<\/i>, 2019, 142: 1\u201334.","DOI":"10.1016\/bs.ai.2019.05.001"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.103","doi-asserted-by":"publisher","unstructured":"Willart MAM, Deswarte K, Pouliot P, et al. Interleukin-1\u03b1 controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33[J]. <i>J Exp Med<\/i>, 2012, 209(8): 1505\u20131517.","DOI":"10.1084\/jem.20112691"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.104","doi-asserted-by":"publisher","unstructured":"Froidure A, Shen C, Pilette C. Dendritic cells revisited in human allergic rhinitis and asthma[J]. <i>Allergy<\/i>, 2016, 71(2): 137\u2013148.","DOI":"10.1111\/all.12770"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.105","doi-asserted-by":"publisher","unstructured":"de Heer HJ, Hammad H, Soulli\u00e9 T, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen[J]. <i>J Exp Med<\/i>, 2004, 200(1): 89\u201398.","DOI":"10.1084\/jem.20040035"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.106","doi-asserted-by":"publisher","unstructured":"Lajiness JD, Amarsaikhan N, Tat K, et al. \u03b2-glucosylceramides and tocopherols regulate development and function of dendritic cells[J]. <i>J Immunol<\/i>, 2022, 209(10): 1837\u20131850.","DOI":"10.4049\/jimmunol.2101188"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.107","doi-asserted-by":"publisher","unstructured":"Coenen I, Jones AC, White AA, et al. Reduced type-I interferon by plasmacytoid dendritic cells and asthma in school-aged children[J]. <i>Allergy<\/i>, 2026, 81(1): 109\u2013120.","DOI":"10.1111\/all.70005"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.108","doi-asserted-by":"publisher","unstructured":"Gill MA, Bajwa G, George TA, et al. Counterregulation between the Fc\u03b5RI pathway and antiviral responses in human plasmacytoid dendritic cells[J]. <i>J Immunol<\/i>, 2010, 184(11): 5999\u20136006.","DOI":"10.4049\/jimmunol.0901194"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.109","doi-asserted-by":"publisher","unstructured":"Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (Anti-IgE) for asthma in inner-city children[J]. <i>N Engl J Med<\/i>, 2011, 364(11): 1005\u20131015.","DOI":"10.1056\/NEJMoa1009705"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.110","doi-asserted-by":"publisher","unstructured":"C\u00e9spedes PF, Bueno SM, Ram\u00edrez BA, et al. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2014, 111(31): E3214\u2013E3223.","DOI":"10.1073\/pnas.1400760111"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.111","doi-asserted-by":"publisher","unstructured":"Wu Y, Mao H, Ling MT, et al. Successive influenza virus infection and <i>Streptococcus pneumoniae<\/i> stimulation alter human dendritic cell function[J]. <i>BMC Infect Dis<\/i>, 2011, 11(1): 201.","DOI":"10.1186\/1471-2334-11-201"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.112","doi-asserted-by":"publisher","unstructured":"Lynch JP, Mazzone SB, Rogers MJ, et al. The plasmacytoid dendritic cell: At the cross-roads in asthma[J]. <i>Eur Respir J<\/i>, 2014, 43(1): 264\u2013275.","DOI":"10.1183\/09031936.00203412"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.113","doi-asserted-by":"publisher","unstructured":"Liew KY, Koh SK, Hooi SL, et al. Rhinovirus-induced cytokine alterations with potential implications in asthma exacerbations: A systematic review and meta-analysis[J]. <i>Front Immunol<\/i>, 2022, 13: 782936.","DOI":"10.3389\/fimmu.2022.782936"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.114","doi-asserted-by":"publisher","unstructured":"Zhang B, Zeng M, Zhang Q, et al. Ephedrae Herba polysaccharides inhibit the inflammation of ovalbumin induced asthma by regulating Th1\/Th2 and Th17\/Treg cell immune imbalance[J]. <i>Mol Immunol<\/i>, 2022, 152: 14\u201326.","DOI":"10.1016\/j.molimm.2022.09.009"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.115","doi-asserted-by":"publisher","unstructured":"Chung KF. Targeting the interleukin pathway in the treatment of asthma[J]. <i>Lancet<\/i>, 2015, 386(9998): 1086\u20131096.","DOI":"10.1016\/S0140-6736(15)00157-9"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.116","doi-asserted-by":"crossref","unstructured":"Gill MA, Liu AH, Calatroni A, et al. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab[J]. <i>J Allergy Clin Immunol<\/i>, 2018, 141(5): 1735\u20131743. e9.","DOI":"10.1016\/j.jaci.2017.07.035"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.117","doi-asserted-by":"publisher","unstructured":"Doe C, Bafadhel M, Siddiqui S, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD[J]. <i>Chest<\/i>, 2010, 138(5): 1140\u20131147.","DOI":"10.1378\/chest.09-3058"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.118","doi-asserted-by":"publisher","unstructured":"Al-Ramli W, Pr\u00e9fontaine D, Chouiali F, et al. T<sub>H<\/sub>17-associated cytokines (IL-17A and IL-17F) in severe asthma[J]. <i>J Allergy Clin Immunol<\/i>, 2009, 123(5): 1185\u20131187.","DOI":"10.1016\/j.jaci.2009.02.024"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.119","doi-asserted-by":"publisher","unstructured":"Ricciardolo FLM, Sorbello V, Folino A, et al. Identification of IL-17F\/frequent exacerbator endotype in asthma[J]. <i>J Allergy Clin Immunol<\/i>, 2017, 140(2): 395\u2013406.","DOI":"10.1016\/j.jaci.2016.10.034"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.120","doi-asserted-by":"publisher","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation[J]. <i>Nat Rev Immunol<\/i>, 2013, 13(3): 159\u2013175.","DOI":"10.1038\/nri3399"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.121","doi-asserted-by":"publisher","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation[J]. <i>Nat Rev Immunol<\/i>, 2013, 13(3): 159\u2013175.","DOI":"10.1038\/nri3399"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.122","doi-asserted-by":"publisher","unstructured":"Ray A, Kolls JK. Neutrophilic inflammation in asthma and association with disease severity[J]. <i>Trends Immunol<\/i>, 2017, 38(12): 942\u2013954.","DOI":"10.1016\/j.it.2017.07.003"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.123","doi-asserted-by":"publisher","unstructured":"van Oosterhout AJM, Bloksma N. Regulatory T-lymphocytes in asthma[J]. <i>Eur Respir J<\/i>, 2005, 26(5): 918\u2013932.","DOI":"10.1183\/09031936.05.00011205"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.124","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy N, Khare A, Oriss TB, et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma[J]. <i>Nat Med<\/i>, 2012, 18(10): 1525\u20131530.","DOI":"10.1038\/nm.2896"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.125","doi-asserted-by":"publisher","unstructured":"Provoost S, Maes T, Van Durme YM, et al. Decreased FOXP3 protein expression in patients with asthma[J]. <i>Allergy<\/i>, 2009, 64(10): 1539\u20131546.","DOI":"10.1111\/j.1398-9995.2009.02056.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.126","doi-asserted-by":"publisher","unstructured":"Josefowicz SZ, Niec RE, Kim HY, et al. Extrathymically generated regulatory T cells control mucosal T<sub>H<\/sub>2 inflammation[J]. <i>Nature<\/i>, 2012, 482(7385): 395\u2013399.","DOI":"10.1038\/nature10772"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.127","doi-asserted-by":"publisher","unstructured":"Harb H, Stephen-Victor E, Crestani E, et al. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma[J]. <i>Nat Immunol<\/i>, 2020, 21(11): 1359\u20131370.","DOI":"10.1038\/s41590-020-0777-3"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.128","doi-asserted-by":"publisher","unstructured":"Geng J, Yu S, Zhao H, et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of T<sub>H<\/sub>17 cells and T<sub>reg<\/sub> cells[J]. <i>Nat Immunol<\/i>, 2017, 18(7): 800\u2013812.","DOI":"10.1038\/ni.3748"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.129","doi-asserted-by":"publisher","unstructured":"Massoud AH, Charbonnier LM, Lopez D, et al. An asthma-associated <i>IL4R<\/i> variant exacerbates airway inflammation by promoting conversion of regulatory T cells to T<sub>H<\/sub>17-like cells[J]. <i>Nat Med<\/i>, 2016, 22(9): 1013\u20131022.","DOI":"10.1038\/nm.4147"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.130","doi-asserted-by":"publisher","unstructured":"Seumois G, Ram\u00edrez-Su\u00e1stegui C, Schmiedel BJ, et al. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma[J]. <i>Sci Immunol<\/i>, 2020, 5(48): eaba6087.","DOI":"10.1126\/sciimmunol.aba6087"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.131","doi-asserted-by":"publisher","unstructured":"Akdis CA, Arkwright PD, Br\u00fcggen MC, et al. Type 2 immunity in the skin and lungs[J]. <i>Allergy<\/i>, 2020, 75(7): 1582\u20131605.","DOI":"10.1111\/all.14318"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.132","doi-asserted-by":"publisher","unstructured":"Ma S, Satitsuksanoa P, Jansen K, et al. B regulatory cells in allergy[J]. <i>Immunol Rev<\/i>, 2021, 299(1): 10\u201330.","DOI":"10.1111\/imr.12937"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.133","doi-asserted-by":"publisher","unstructured":"Habener A, Grychtol R, Gaedcke S, et al. IgA<sup>+<\/sup> memory B-cells are significantly increased in patients with asthma and small airway dysfunction[J]. <i>Eur Respir J<\/i>, 2022, 60(5): 2102130.","DOI":"10.1183\/13993003.02130-2021"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.134","doi-asserted-by":"publisher","unstructured":"Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children[J]. <i>J Allergy Clin Immunol<\/i>, 2017, 140(4): 895\u2013906.","DOI":"10.1016\/j.jaci.2017.08.003"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.135","doi-asserted-by":"crossref","unstructured":"Bergroth E, Aakula M, Elenius V, et al. Rhinovirus type in severe bronchiolitis and the development of asthma[J]. <i>J Allergy Clin Immunol Pract<\/i>, 2020, 8(2): 588\u2013595. e4.","DOI":"10.1016\/j.jaip.2019.08.043"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.136","doi-asserted-by":"publisher","unstructured":"Ladjemi MZ, Gras D, Dupasquier S, et al. Bronchial epithelial IgA secretion is impaired in asthma. role of IL-4\/IL-13[J]. <i>Am J Respir Crit Care Med<\/i>, 2018, 197(11): 1396\u20131409.","DOI":"10.1164\/rccm.201703-0561OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.137","doi-asserted-by":"publisher","unstructured":"Smits HH, Gloudemans AK, van Nimwegen M, et al. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA[J]. <i>Mucosal Immunol<\/i>, 2009, 2(4): 331\u2013339.","DOI":"10.1038\/mi.2009.16"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.138","doi-asserted-by":"publisher","unstructured":"Andreychyn M, Melnyk L, Zavidniiuk N, et al. Interleukins in the pathogenesis of influenza and other acute respiratory viral infections[J]. <i>Epidemiol Infect<\/i>, 2024, 152: e109.","DOI":"10.1017\/S0950268824001109"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.139","doi-asserted-by":"publisher","unstructured":"Li W, Wu Y, Zhao Y, et al. MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation[J]. <i>Thorax<\/i>, 2020, 75(12): 1047\u20131057.","DOI":"10.1136\/thoraxjnl-2019-213771"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.140","doi-asserted-by":"publisher","unstructured":"Gavala ML, Bashir H, Gern JE. Virus\/allergen interactions in asthma[J]. <i>Curr Allergy Asthma Rep<\/i>, 2013, 13(3): 298\u2013307.","DOI":"10.1007\/s11882-013-0344-1"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.141","doi-asserted-by":"crossref","unstructured":"Smith SG, Chen R, Kjarsgaard M, et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia[J]. <i>J Allergy Clin Immunol<\/i>, 2016, 137(1): 75\u201386. e8.","DOI":"10.1016\/j.jaci.2015.05.037"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.142","doi-asserted-by":"publisher","unstructured":"Chen R, Smith SG, Salter B, et al. Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma[J]. <i>Am J Respir Crit Care Med<\/i>, 2017, 196(6): 700\u2013712.","DOI":"10.1164\/rccm.201612-2427OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.143","doi-asserted-by":"publisher","unstructured":"Xu D, Jiang HR, Kewin P, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2008, 105(31): 10913\u201310918.","DOI":"10.1073\/pnas.0801898105"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.144","doi-asserted-by":"publisher","unstructured":"Hu L, Sun L, Yang C, et al. Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions[J]. <i>J Transl Med<\/i>, 2024, 22(1): 570.","DOI":"10.1186\/s12967-024-05376-4"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.145","doi-asserted-by":"publisher","unstructured":"Rohde G, Message SD, Haas JJ, et al. CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations[J]. <i>Clin Exp Allergy<\/i>, 2014, 44(7): 930\u2013939.","DOI":"10.1111\/cea.12313"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.146","doi-asserted-by":"publisher","unstructured":"Spalluto CM, Singhania A, Cellura D, et al. IFN-\u03b3 influences epithelial antiviral responses via histone methylation of the <i>RIG-I<\/i> promoter[J]. <i>Am J Respir Cell Mol Biol<\/i>, 2017, 57(4): 428\u2013438.","DOI":"10.1165\/rcmb.2016-0392OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.147","doi-asserted-by":"publisher","unstructured":"Yang J, Tian B, Sun H, et al. Epigenetic silencing of <i>IRF1<\/i> dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition[J]. <i>Nat Microbiol<\/i>, 2017, 2(8): 17086.","DOI":"10.1038\/nmicrobiol.2017.86"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.148","doi-asserted-by":"publisher","unstructured":"Cheng Q, He F, Zhao W, et al. Histone acetylation regulates ORMDL3 expression-mediated NLRP3 inflammasome overexpression during RSV-allergic exacerbation mice[J]. <i>J Cell Physiol<\/i>, 2023, 238(12): 2904\u20132923.","DOI":"10.1002\/jcp.31141"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.149","doi-asserted-by":"crossref","unstructured":"Rathod A, Rathod R, Zhang H, et al. Association of asthma and rhinitis with epigenetics of coronavirus related genes[J]. <i>Epigenet Insights<\/i>, 2021, 14: 25168657211039224.","DOI":"10.1177\/25168657211039224"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.150","unstructured":"Alizadeh Z, Mortaz E, Adcock I, et al. Role of epigenetics in the pathogenesis of asthma[J]. <i>Iran J Allergy Asthma Immunol<\/i>, 2017, 16(2): 82\u201391."},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.151","doi-asserted-by":"publisher","unstructured":"Ren Y, Li M, Bai S, et al. Identification of histone acetylation in a murine model of allergic asthma by proteomic analysis[J]. <i>Exp Biol Med (Maywood)<\/i>, 2021, 246(8): 929\u2013939.","DOI":"10.1177\/1535370220980345"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.152","doi-asserted-by":"publisher","unstructured":"Alaskhar Alhamwe B, Khalaila R, Wolf J, et al. Histone modifications and their role in epigenetics of atopy and allergic diseases[J]. <i>Allergy Asthma Clin Immunol<\/i>, 2018, 14(1): 39.","DOI":"10.1186\/s13223-018-0259-4"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.153","doi-asserted-by":"publisher","unstructured":"Clifford RL, Patel JK, John AE, et al. CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: Regulation by BET[J]. <i>Am J Physiol Lung Cell Mol Physiol<\/i>, 2015, 308(9): L962\u2013L972.","DOI":"10.1152\/ajplung.00021.2015"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.154","doi-asserted-by":"publisher","unstructured":"Chiappara G, Chanez P, Bruno A, et al. Variable p-CREB expression depicts different asthma phenotypes[J]. <i>Allergy<\/i>, 2007, 62(7): 787\u2013794.","DOI":"10.1111\/j.1398-9995.2007.01417.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.155","doi-asserted-by":"publisher","unstructured":"Funchal GA, Jaeger N, Czepielewski RS, et al. Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils[J]. <i>PLoS One<\/i>, 2015, 10(4): e0124082.","DOI":"10.1371\/journal.pone.0124082"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.156","doi-asserted-by":"publisher","unstructured":"Toussaint M, Jackson DJ, Swieboda D, et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation[J]. <i>Nat Med<\/i>, 2017, 23(6): 681\u2013691.","DOI":"10.1038\/nm.4332"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.157","doi-asserted-by":"publisher","unstructured":"Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19[J]. <i>JCI Insight<\/i>, 2020, 5(11): e138999.","DOI":"10.1172\/jci.insight.138999"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.158","doi-asserted-by":"publisher","unstructured":"Veras FP, Pontelli MC, Silva CM, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology[J]. <i>J Exp Med<\/i>, 2020, 217(12): e20201129.","DOI":"10.1084\/jem.20201129"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.159","doi-asserted-by":"publisher","unstructured":"Tripathi S, Verma A, Kim EJ, et al. LL-37 modulates human neutrophil responses to influenza A virus[J]. <i>J Leukoc Biol<\/i>, 2014, 96(5): 931\u2013938.","DOI":"10.1189\/jlb.4A1113-604RR"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.160","doi-asserted-by":"publisher","unstructured":"Mutua V, Cavallo F, Gershwin LJ. Neutrophil extracellular traps (NETs) in a randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection[J]. <i>Vet Immunol Immunopathol<\/i>, 2021, 241: 110323.","DOI":"10.1016\/j.vetimm.2021.110323"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.161","doi-asserted-by":"publisher","unstructured":"Gringhuis SI, van der Vlist M, van den Berg LM, et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells[J]. <i>Nat Immunol<\/i>, 2010, 11(5): 419\u2013426.","DOI":"10.1038\/ni.1858"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.162","doi-asserted-by":"publisher","unstructured":"Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones[J]. <i>PLoS One<\/i>, 2012, 7(2): e32366.","DOI":"10.1371\/journal.pone.0032366"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.163","doi-asserted-by":"publisher","unstructured":"Jenne CN, Wong CHY, Zemp FJ, et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps[J]. <i>Cell Host Microbe<\/i>, 2013, 13(2): 169\u2013180.","DOI":"10.1016\/j.chom.2013.01.005"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.164","doi-asserted-by":"publisher","unstructured":"Wright TK, Gibson PG, Simpson JL, et al. Neutrophil extracellular traps are associated with inflammation in chronic airway disease[J]. <i>Respirology<\/i>, 2016, 21(3): 467\u2013475.","DOI":"10.1111\/resp.12730"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.165","doi-asserted-by":"publisher","unstructured":"Pham DL, Ban GY, Kim SH, et al. Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma[J]. <i>Clin Exp Allergy<\/i>, 2017, 47(1): 57\u201370.","DOI":"10.1111\/cea.12859"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.166","doi-asserted-by":"publisher","unstructured":"Stojkov D, Yousefi S, Simon HU. NETs: Important players in asthma?[J]. <i>J Allergy Clin Immunol<\/i>, 2024, 153(1): 100\u2013102.","DOI":"10.1016\/j.jaci.2023.09.031"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.167","doi-asserted-by":"publisher","unstructured":"He X, Zhang L, Xiong A, et al. PM<sub>2.5<\/sub> aggravates NQO1-induced mucus hyper-secretion through release of neutrophil extracellular traps in an asthma model[J]. <i>Ecotoxicol Environ Saf<\/i>, 2021, 218: 112272.","DOI":"10.1016\/j.ecoenv.2021.112272"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.168","doi-asserted-by":"publisher","unstructured":"Linssen RS, Chai G, Ma J, et al. Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit[J]. <i>Am J Respir Cell Mol Biol<\/i>, 2021, 64(1): 69\u201378.","DOI":"10.1165\/rcmb.2020-0168OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.169","doi-asserted-by":"publisher","unstructured":"Yang M, Chen Q, Mei L, et al. Neutrophil elastase promotes neointimal hyperplasia by targeting toll-like receptor 4 (TLR4)-NF-\u03baB signalling[J]. <i>Br J Pharmacol<\/i>, 2021, 178(20): 4048\u20134068.","DOI":"10.1111\/bph.15583"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.170","doi-asserted-by":"publisher","unstructured":"Curren B, Ahmed T, Howard DR, et al. IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma[J]. <i>Mucosal Immunol<\/i>, 2023, 16(5): 671\u2013684.","DOI":"10.1016\/j.mucimm.2023.07.002"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.171","doi-asserted-by":"publisher","unstructured":"Grier A, McDavid A, Wang B, et al. Neonatal gut and respiratory microbiota: Coordinated development through time and space[J]. <i>Microbiome<\/i>, 2018, 6(1): 193.","DOI":"10.1186\/s40168-018-0566-5"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.172","doi-asserted-by":"publisher","unstructured":"Rajagopala SV, Bakhoum NG, Pakala SB, et al. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples[J]. <i>Cell Rep Methods<\/i>, 2021, 1(6): 100091.","DOI":"10.1016\/j.crmeth.2021.100091"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.173","doi-asserted-by":"publisher","unstructured":"Essilfie AT, Simpson JL, Horvat JC, et al. <i>Haemophilus influenzae<\/i> infection drives IL-17-mediated neutrophilic allergic airways disease[J]. <i>PLoS Pathog<\/i>, 2011, 7(10): e1002244.","DOI":"10.1371\/journal.ppat.1002244"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.174","doi-asserted-by":"publisher","unstructured":"Looft T, Allen HK. Collateral effects of antibiotics on mammalian gut microbiomes[J]. <i>Gut Microbes<\/i>, 2012, 3(5): 463\u2013467.","DOI":"10.4161\/gmic.21288"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.175","doi-asserted-by":"publisher","unstructured":"Deriu E, Boxx GM, He X, et al. Influenza virus affects intestinal microbiota and secondary <i>salmonella<\/i> infection in the gut through type I interferons[J]. <i>PLoS Pathog<\/i>, 2016, 12(5): e1005572.","DOI":"10.1371\/journal.ppat.1005572"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.176","doi-asserted-by":"publisher","unstructured":"Baradaran Ghavami S, Pourhamzeh M, Farmani M, et al. Cross-talk between immune system and microbiota in COVID-19[J]. <i>Expert Rev Gastroenterol Hepatol<\/i>, 2021, 15(11): 1281\u20131294.","DOI":"10.1080\/17474124.2021.1991311"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.177","doi-asserted-by":"publisher","unstructured":"Anand S, Mande SS. Diet, microbiota and gut-lung connection[J]. <i>Front Microbiol<\/i>, 2018, 9: 2147.","DOI":"10.3389\/fmicb.2018.02147"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.178","doi-asserted-by":"publisher","unstructured":"Shi N, Li N, Duan X, et al. Interaction between the gut microbiome and mucosal immune system[J]. <i>Mil Med Res<\/i>, 2017, 4(1): 14.","DOI":"10.1186\/s40779-017-0122-9"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.179","doi-asserted-by":"publisher","unstructured":"Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity[J]. <i>Immunity<\/i>, 2012, 37(1): 158\u2013170.","DOI":"10.1016\/j.immuni.2012.04.011"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.180","doi-asserted-by":"publisher","unstructured":"Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2011, 108(13): 5354\u20135359.","DOI":"10.1073\/pnas.1019378108"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.181","doi-asserted-by":"publisher","unstructured":"Nagata N, Takeuchi T, Masuoka H, et al. Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications[J]. <i>Gastroenterology<\/i>, 2023, 164(2): 272\u2013288.","DOI":"10.1053\/j.gastro.2022.09.024"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.182","doi-asserted-by":"publisher","unstructured":"Tang J, Xu L, Zeng Y, et al. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4\/NF-kB signaling pathway[J]. <i>Int Immunopharmacol<\/i>, 2021, 91: 107272.","DOI":"10.1016\/j.intimp.2020.107272"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.183","doi-asserted-by":"publisher","unstructured":"Stolfi C, Maresca C, Monteleone G, et al. Implication of intestinal barrier dysfunction in gut dysbiosis and diseases[J]. <i>Biomedicines<\/i>, 2022, 10(2): 289.","DOI":"10.3390\/biomedicines10020289"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.184","doi-asserted-by":"publisher","unstructured":"Dang AT, Begka C, Pattaroni C, et al. Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung[J]. <i>Mucosal Immunol<\/i>, 2023, 16(4): 476\u2013485.","DOI":"10.1016\/j.mucimm.2023.05.005"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.185","doi-asserted-by":"publisher","unstructured":"Liu X, Shao J, Liao Y, et al. Regulation of short-chain fatty acids in the immune system[J]. <i>Front Immunol<\/i>, 2023, 14: 1186892.","DOI":"10.3389\/fimmu.2023.1186892"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.186","doi-asserted-by":"publisher","unstructured":"Ziaka M, Exadaktylos A. Gut-derived immune cells and the gut-lung axis in ARDS[J]. <i>Crit Care<\/i>, 2024, 28(1): 220.","DOI":"10.1186\/s13054-024-05006-x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.187","doi-asserted-by":"publisher","unstructured":"Finotto S, Jartti T, Johnston SL. Editorial: Type I and type III interferon immune responses in asthma[J]. <i>Front Immunol<\/i>, 2022, 12: 826363.","DOI":"10.3389\/fimmu.2021.826363"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.188","doi-asserted-by":"publisher","unstructured":"Simon HU, Seelbach H, Ehmann R, et al. Clinical and immunological effects of low-dose IFN\u2013<i>\u03b1<\/i> treatment in patients with corticosteroid-resistant asthma[J]. <i>Allergy<\/i>, 2003, 58(12): 1250\u20131255.","DOI":"10.1046\/j.1398-9995.2003.00424.x"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.189","doi-asserted-by":"publisher","unstructured":"Djukanovi\u0107 R, Harrison T, Johnston SL, et al. The effect of inhaled IFN-\u03b2 on worsening of asthma symptoms caused by viral infections. A randomized trial[J]. <i>Am J Respir Crit Care Med<\/i>, 2014, 190(2): 145\u2013154.","DOI":"10.1164\/rccm.201312-2235OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.190","doi-asserted-by":"publisher","unstructured":"McCrae C, Olsson M, Gustafson P, et al. INEXAS: A phase 2 randomized trial of on-demand inhaled interferon beta-1a in severe asthmatics[J]. <i>Clin Exp Allergy<\/i>, 2021, 51(2): 273\u2013283.","DOI":"10.1111\/cea.13765"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.191","doi-asserted-by":"crossref","unstructured":"Jha A, Thwaites RS, Tunstall T, et al. Increased nasal mucosal interferon and CCL13 response to a TLR7\/8 agonist in asthma and allergic rhinitis[J]. <i>J Allergy Clin Immunol<\/i>, 2021, 147(2): 694\u2013703. e12.","DOI":"10.1016\/j.jaci.2020.07.012"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.192","doi-asserted-by":"publisher","unstructured":"Langenickel T, Tomkinson N, Strohwasser J, et al. ETH47 is a novel mRNA drug candidate for the prevention of asthma exacerbations[J]. <i>Eur Respir J<\/i>, 2025, 66(S69): OA1189.","DOI":"10.1183\/13993003.congress-2025.oa1189"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.193","doi-asserted-by":"publisher","unstructured":"Ombredane H, Daly L, Moen A, et al. Effects of an anti-viral interferon booster, RIG-I agonist (RIG-101), on influenza infection <i>in vitro<\/i> and <i>in vivo<\/i>[J]. <i>Eur Respir J<\/i>, 2024, 64(S68): OA5462.","DOI":"10.1183\/13993003.congress-2024.oa5462"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.194","doi-asserted-by":"publisher","unstructured":"Weinstein CLJ, Ryan N, Shekar T, et al. Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate[J]. <i>J Allergy Clin Immunol<\/i>, 2019, 143(4): 1395\u20131402.","DOI":"10.1016\/j.jaci.2018.10.065"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.195","doi-asserted-by":"publisher","unstructured":"Simpson JL, Carroll M, Yang IA, et al. Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids[J]. <i>Chest<\/i>, 2016, 149(3): 704\u2013713.","DOI":"10.1016\/j.chest.2015.12.018"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.196","doi-asserted-by":"publisher","unstructured":"Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations[J]. <i>J Allergy Clin Immunol<\/i>, 2015, 136(6): 1476\u20131485.","DOI":"10.1016\/j.jaci.2015.09.008"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.197","doi-asserted-by":"publisher","unstructured":"Maglione M, Borrelli M, Dorato A, et al. Mepolizumab in severe pediatric asthma: Certainties and doubts through a single-center experience and review of the literature[J]. <i>Children<\/i>, 2024, 11(8): 895.","DOI":"10.3390\/children11080895"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.198","doi-asserted-by":"publisher","unstructured":"Contoli M, Papi A. Effects of anti-IL-5 on virus-induced exacerbation in asthma. light and shadow[J]. <i>Am J Respir Crit Care Med<\/i>, 2019, 199(4): 410\u2013411.","DOI":"10.1164\/rccm.201809-1684ED"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.199","doi-asserted-by":"publisher","unstructured":"McDowell PJ, Diver S, Yang F, et al. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): A prospective observational study[J]. <i>Lancet Respir Med<\/i>, 2021, 9(10): 1174\u20131184.","DOI":"10.1016\/S2213-2600(21)00004-7"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.200","doi-asserted-by":"publisher","unstructured":"Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma[J]. <i>N Engl J Med<\/i>, 2018, 378(26): 2486\u20132496.","DOI":"10.1056\/NEJMoa1804092"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.201","doi-asserted-by":"publisher","unstructured":"Contoli M, Ito K, Padovani A, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells[J]. <i>Allergy<\/i>, 2015, 70(8): 910\u2013920.","DOI":"10.1111\/all.12627"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.202","doi-asserted-by":"publisher","unstructured":"Geng B, Bachert C, Busse WW, et al. Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies[J]. <i>J Allergy Clin Immunol Pract<\/i>, 2022, 10(3): 732\u2013741.","DOI":"10.1016\/j.jaip.2021.12.006"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.203","doi-asserted-by":"publisher","unstructured":"Hammad H, Ahmed E, Lambrecht BN. Immunotherapy for asthma[J]. <i>Cell Mol Immunol<\/i>, 2025, 22(12): 1521\u20131532.","DOI":"10.1038\/s41423-025-01357-9"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.204","doi-asserted-by":"publisher","unstructured":"Corren J, Menzies-Gow A, Chupp G, et al. Efficacy of tezepelumab in severe, uncontrolled asthma: Pooled analysis of the PATHWAY and NAVIGATOR clinical trials[J]. <i>Am J Respir Crit Care Med<\/i>, 2023, 208(1): 13\u201324.","DOI":"10.1164\/rccm.202210-2005OC"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.205","doi-asserted-by":"crossref","unstructured":"Pavord ID, Hoyte FCL, Lindsley AW, et al. Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)[J]. <i>Ann Allergy Asthma Immunol<\/i>, 2023, 131(5): 587\u2013597. e3.","DOI":"10.1016\/j.anai.2023.08.015"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.206","doi-asserted-by":"publisher","unstructured":"Kuchibhotla VNS, Starkey MR, Reid AT, et al. Inhibition of \u03b2-catenin\/CREB binding protein signaling attenuates house dust mite-induced goblet cell metaplasia in mice[J]. <i>Front Physiol<\/i>, 2021, 12: 690531.","DOI":"10.3389\/fphys.2021.690531"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.207","doi-asserted-by":"publisher","unstructured":"Sun Z, Ji N, Ma Q, et al. Epithelial-mesenchymal transition in asthma airway remodeling is regulated by the IL-33\/CD146 axis[J]. <i>Front Immunol<\/i>, 2020, 11: 1598.","DOI":"10.3389\/fimmu.2020.01598"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.208","doi-asserted-by":"publisher","unstructured":"Noureddine N, Chalubinski M, Wawrzyniak P. The role of defective epithelial barriers in allergic lung disease and asthma development[J]. <i>J Asthma Allergy<\/i>, 2022, 15: 487\u2013504.","DOI":"10.2147\/JAA.S324080"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.209","doi-asserted-by":"publisher","unstructured":"Georas SN. Targeting histone deacetylases to restore epithelial barrier integrity: A new option for personalized medicine in patients with allergic airway disorders?[J]. <i>J Allergy Clin Immunol<\/i>, 2019, 144(5): 1172\u20131174.","DOI":"10.1016\/j.jaci.2019.09.007"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.210","doi-asserted-by":"crossref","unstructured":"Kelleher K, Subramaniam N, Drysdale SB. The recent landscape of RSV vaccine research[J]. <i>Ther Adv Vaccines Immunother<\/i>, 2025, 13: 25151355241310601.","DOI":"10.1177\/25151355241310601"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.211","doi-asserted-by":"publisher","unstructured":"Britton A, Roper LE, Kotton CN, et al. Use of respiratory syncytial virus vaccines in adults aged \u226560 years: Updated recommendations of the advisory committee on immunization practices - United States, 2024[J]. <i>MMWR Morb Mortal Wkly Rep<\/i>, 2024, 73(32): 696\u2013702.","DOI":"10.15585\/mmwr.mm7332e1"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.212","doi-asserted-by":"publisher","unstructured":"Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: Recommendations of the advisory committee on immunization practices - United States, 2023[J]. <i>MMWR Morb Mortal Wkly Rep<\/i>, 2023, 72(41): 1115\u20131122.","DOI":"10.15585\/mmwr.mm7241e1"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.213","doi-asserted-by":"publisher","unstructured":"Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants[J]. <i>N Engl J Med<\/i>, 2022, 386(9): 837\u2013846.","DOI":"10.1056\/NEJMoa2110275"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.214","doi-asserted-by":"publisher","unstructured":"Begg M, Pyle CJ, Patel N, et al. APL-10456; An adjuvanted rhinovirus clinical vaccine candidate which generates cross-species humoral and th1-polarized cellular immunity[J]. <i>Am J Respir Crit Care Med<\/i>, 2025, 211(S1): A3550\u2013A3550.","DOI":"10.1164\/ajrccm.2025.211.abstracts.a3550"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.215","doi-asserted-by":"publisher","unstructured":"Johnston SL, Laessig K, Edwards MR, et al. Late Breaking Abstract - Vapendavir for the treatment of COPD patients challenged with rhinovirus: A phase 2a placebo-controlled study[J]. <i>Eur Respir J<\/i>, 2025, 66(S69): PA4772.","DOI":"10.1183\/13993003.congress-2025.pa4772"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.216","doi-asserted-by":"publisher","unstructured":"Kim MH, Song WJ, Yang MS, et al. Clinical course of asthma patients with H1N1 influenza infection and oseltamivir[J]. <i>Minerva Med<\/i>, 2018, 109(1): 7\u201314.","DOI":"10.23736\/s0026-4806.17.05329-0"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.217","doi-asserted-by":"publisher","unstructured":"Hazan G, Fox C, Eiden E, et al. Effect of the COVID-19 lockdown on asthma biological rhythms[J]. <i>J Biol Rhythms<\/i>, 2022, 37(2): 152\u2013163.","DOI":"10.1177\/07487304221081730"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.218","doi-asserted-by":"publisher","unstructured":"Shah SA, Quint JK, Sheikh A. Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500, 000 patients in a national English primary care database[J]. <i>Lancet Reg Health Europe<\/i>, 2022, 19: 100428.","DOI":"10.1016\/j.lanepe.2022.100428"},{"key":"10.7555\/JBR.40.20260243.swyxyjzzywb.219","doi-asserted-by":"crossref","unstructured":"Tydeman F, Pfeffer PE, Vivaldi G, et al. Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: A longitudinal population-based study (COVIDENCE UK)[J]. <i>Thorax<\/i>, 2023, 78(8): 752\u2013759.","DOI":"10.1101\/2022.09.01.22279473"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:56:09Z","timestamp":1785423369000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.40.20260243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":219,"alternative-id":["JBR-2026-0243"],"URL":"https:\/\/doi.org\/10.7555\/jbr.40.20260243","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}